REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/27/2026
Back to search
Official data from USPTO
MOGRIFY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MOGRIFY
ST13
US500000079289697Class
1, 5, 9, 40, 42, 44
Filing
79289697
Registration
6430514
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
07/27/2026
Trademark type
Word
Nice classes
1, 5, 9, 40, 42, 44
Filing date
05/13/2020
Registration date
07/27/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/27/2021
Last transaction
07/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
MASON, JARED MICHAEL
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Mogrify Limited
Representatives
Rebecca Liebowitz Venable LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents for research purposes; molecular biology research tools in the nature of biologicalchemical and biochemical reagents for research use
Class 5
Medical and veterinary preparations for therapeutic purposesnamely pharmaceutical and biopharmaceutical preparations for the treatment of ophthalmological conditionshematologic diseasesimmune response disordersneurological disordersrespiratory diseasesmetabolic diseasesgenetic conditionscancerinfectious diseases and cardiovascular diseases; pharmaceutical and biopharmaceutical preparations for cell therapy; pharmaceutical and biopharmaceutical preparations for modifying human or animal cells for medical or therapeutic purposes; biologicalchemical and biochemical reagents for medical use
Class 9
Downloadable bioinformatics software for genomic data analysis; downloadable computer software platforms for genomic data analysis in the fields of ophthalmologyhaematologyimmunologyneurologyrespiratory diseasesmetabolic conditionsgenetic conditionsoncologyimmuno-oncologyinfectious diseases and cardiovascular diseases; scientific apparatus for measuring and analysing scientific study data in the nature of apparatus for recordingtransmission or reproduction of data including videoaudioimages and text; data analysis apparatus in the nature of data processing equipment and computers and downloadable operating computer software sold as a unit; downloadable scientific data analysis software
Class 40
Treatment and processing of biological materialsnamely cellsstem cellsinduced pluripotent stem cells; custom manufacture of therapeutic drugsnamely custom manufacture of transcription factorscells and cell therapiesgene therapies ; informationadvisory and consultancy services in relation to all of the aforesaid services
Class 42
Scientific and technological servicesresearch and design in the fields of ophthalmologyhaematologyimmunologyneurologyrespiratory diseasesmetabolic conditionsgenetic conditionsoncologyimmuno-oncologyinfectious diseases and cardiovascular diseases; industrial research services in the field of cell therapies and gene therapies; medical and veterinary research services in the nature of the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; design and development of new products for others; scientific laboratory services; software as a service (SaaS) services featuring software for use in genomic data analysis; platform as a service (Paas) services that feature a computer bioinformatics platform for use in manufacturing therapeutics; providing a bioinformatics platform for identifying transcription factors to turn one cell type into another cell type; advisory and consultancy relating to all the aforesaid services
Class 44
Medical services; veterinary services; medical services for the treatment of conditions of the human or animal body; medical services in the nature of manipulation of human and animal cells for therapeutic purposes; providing advice and consultancy in the field of medical and veterinary therapies
Publications
History of USPTO decisions and trademark events.
32 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/04/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/13/2021
FIMP
FINAL DISPOSITION PROCESSED
12/13/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/27/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
07/27/2021
GPNX
NOTIFICATION PROCESSED BY IB
05/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/11/2021
PUBO
PUBLISHED FOR OPPOSITION
05/11/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/21/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/21/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/21/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/02/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
04/02/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/02/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
04/02/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/02/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/25/2021
GNFR
FINAL REFUSAL E-MAILED
03/25/2021
CNFR
FINAL REFUSAL WRITTEN
03/25/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/04/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/04/2021
RFNT
REFUSAL PROCESSED BY IB
10/04/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/11/2020
RFRR
REFUSAL PROCESSED BY MPU
09/11/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/12/2020
CNRT
NON-FINAL ACTION WRITTEN
08/11/2020
DOCK
ASSIGNED TO EXAMINER
08/10/2020
MAFR
APPLICATION FILING RECEIPT MAILED
07/25/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/21/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/16/2020
Continuous trademark protection
Get notified about every new filing that threatens MOGRIFY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.